The Biotech Growth Trust PLC (BIOG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, The Biotech Growth Trust PLC (BIOG) has a cash flow conversion efficiency ratio of -0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-2.52 Million ≈ $-306.25 USD) by net assets (GBX257.88 Million ≈ $31.38K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
The Biotech Growth Trust PLC - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how The Biotech Growth Trust PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read The Biotech Growth Trust PLC (BIOG) financial obligations for a breakdown of total debt and financial obligations.
The Biotech Growth Trust PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of The Biotech Growth Trust PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Magnetic North Acquisition Corp
V:MNC
|
0.115x |
|
Sabio Holdings Inc
V:SBIO
|
-0.163x |
|
Fidelity Japanese Values PLC ORD
LSE:FJV
|
-0.002x |
|
Springs Global Participações S.A.
SA:SGPS3
|
0.044x |
|
Miramar Resources Ltd
AU:M2R
|
-0.007x |
|
Appulse Corp
V:APL
|
0.003x |
|
NORTHSTAR GOLD CORP.
F:3WV
|
N/A |
|
Millennium Silver Corp
V:MSC
|
0.037x |
Annual Cash Flow Conversion Efficiency for The Biotech Growth Trust PLC (2012–2025)
The table below shows the annual cash flow conversion efficiency of The Biotech Growth Trust PLC from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see The Biotech Growth Trust PLC (BIOG) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | GBX221.21 Million ≈ $26.91K |
GBX-5.09 Million ≈ $-618.94 |
-0.023x | -95.92% |
| 2024-03-31 | GBX361.31 Million ≈ $43.96K |
GBX-4.24 Million ≈ $-516.01 |
-0.012x | +34.18% |
| 2023-03-31 | GBX330.29 Million ≈ $40.19K |
GBX-5.89 Million ≈ $-716.64 |
-0.018x | +42.10% |
| 2022-03-31 | GBX394.21 Million ≈ $47.96K |
GBX-12.14 Million ≈ $-1.48K |
-0.031x | -226.48% |
| 2021-03-31 | GBX601.47 Million ≈ $73.18K |
GBX-5.67 Million ≈ $-690.36 |
-0.009x | +8.40% |
| 2020-03-31 | GBX365.57 Million ≈ $44.48K |
GBX-3.77 Million ≈ $-458.09 |
-0.010x | +4.27% |
| 2019-03-31 | GBX408.88 Million ≈ $49.75K |
GBX-4.40 Million ≈ $-535.23 |
-0.011x | -9.39% |
| 2018-03-31 | GBX417.40 Million ≈ $50.79K |
GBX-4.11 Million ≈ $-499.46 |
-0.010x | +16.56% |
| 2017-03-31 | GBX448.41 Million ≈ $54.56K |
GBX-5.29 Million ≈ $-643.03 |
-0.012x | +24.47% |
| 2016-03-31 | GBX378.57 Million ≈ $46.06K |
GBX-5.91 Million ≈ $-718.71 |
-0.016x | -1283.70% |
| 2015-03-31 | GBX533.30 Million ≈ $64.89K |
GBX703.00K ≈ $85.53 |
0.001x | +100.86% |
| 2014-03-31 | GBX340.25 Million ≈ $41.40K |
GBX-52.25 Million ≈ $-6.36K |
-0.154x | -3352.62% |
| 2013-03-31 | GBX244.44 Million ≈ $29.74K |
GBX1.15 Million ≈ $140.41 |
0.005x | +267.90% |
| 2012-03-31 | GBX156.13 Million ≈ $19.00K |
GBX-439.00K ≈ $-53.41 |
-0.003x | -- |
About The Biotech Growth Trust PLC
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create … Read more